Seoul, South Korea

Chul-Woo Yang

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: The Catholic University of Korea, The Catholic University of Korea Industry-Academic Corporation Foundation. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chul-Woo Yang. Retrieved from https://idiyas.com/inventor/chul-woo-yang-i9wnfves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Sure, here is the article about inventor Chul-Woo Yang:

Title: Innovator Spotlight: Chul-Woo Yang - Pioneering Advancements in Immune Disorder Treatments

Introduction:

In the bustling city of Seoul, South Korea, inventor Chul-Woo Yang has been making significant strides in the field of pharmaceutics, particularly in the area of treating immune disorders and transplantation rejection diseases. With an impressive tally of five patents under his belt, Yang's innovative compositions have the potential to revolutionize the way these conditions are managed.

Latest Patents:

One of Yang's latest patents is a composition aimed at preventing and treating transplant rejection or transplant rejection diseases. This composition, comprising a novel compound and a calcineurin inhibitor, demonstrates remarkable properties such as reducing the activity of pathogenic cells, enhancing the activity of regulatory cells, and inhibiting various pathogenic pathways. Another notable patent by Yang is a pharmaceutical composition containing a biguanide derivative compound, which effectively prevents and treats immune diseases by modulating inflammatory cytokines and promoting regulatory T cell activity.

Career Highlights:

Chul-Woo Yang has made substantial contributions while working at The Catholic University of Korea Industry-academic Cooperation Foundation and The Catholic University of Korea Industry-academic Corporation Foundation. His dedication to research and development has led to breakthrough innovations that have the potential to improve the lives of individuals suffering from immune disorders.

Collaborations:

Throughout his career, Yang has collaborated with esteemed colleagues such as Mi-La Cho and Dong-Yun Shin. Their collective expertise and shared vision have played a pivotal role in advancing the field of immune disorder treatments and transplantation rejection management.

Conclusion:

In conclusion, Chul-Woo Yang's passion for scientific exploration and commitment to innovation have positioned him as a leading figure in the realm of pharmaceutics. His pioneering work in developing novel compositions for immune disorder treatments holds promise for a brighter future in healthcare. As Yang continues to push the boundaries of traditional medicine, his contributions are sure to leave a lasting impact on the field of medicine and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…